Stay updated with the latest confidence-interval news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on confidence-interval topics.
Hyderabad: CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, on Monday said it has reported positive top-line Phase 3 results for BP11, its investigational biosimilar to Xolair, or omalizumab.CuraTeQ said the study met all primary endpoints in patients with chronic spontaneous urticaria receiving the 300 mg dose, demonstrating high comparability with the reference product. The company said it plans to use the results to support regulatory submissions for chronic spontaneous urtic ...Read More >
Hyderabad, April 6 (RAHNUMA): CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has announced positive top-line results from its Phase 3 trial of BP11, an investigational biosimilar to Omalizumab (marketed as Xolair). The study met all primary endpoints, demonstrating strong comparability with the reference drug in treating chronic spontaneous urticaria (CSU) at a 300 mg dose. Conducted across 608 patients at nearly 80 sites in Europe and India, the trial showed precise equivalence in itch s ...Read More >
The study highlights a growing preference for certifications over degrees and emphasizes diversity-led skilling to address talent gaps. Organizations are boosting learning budgets and embracing inclusive strategies to prepare the workforce for evolving industry demands. NIIT Ltd. today launched the NIIT India Skills Gap Report 2026, a nationwide study conducted in partnership with YouGov. The survey, based on insights from 3,500 respondents spanning students, working professionals, recruiters, ...Read More >
New Delhi: NIIT Ltd, launched the NIIT India Skills Gap Report 2026, a nationwide study conducted in partnership with YouGov. The survey, based on insights from 3,500 respondents spanning students, working professionals, recruiters, CXOs and academic leaders across key sectors, highlights how digital, data and cybersecurity skills are emerging as foundational capabilities for employability and workforce growth, while industry-recognised certifications and diversity-led skilling are increasingly ...Read More >
New Delhi [India], July 10 (ANI): The Central Government is aiming to eliminate Rabies by 2030. According to the study done by the Indian Council of Medical Research (ICMR)-National Institute of Epidemiology (NIE), on Human rabies death and animal bite burden estimates in India, 2022-2023, more than 5000 people die every year due to dog bites. Nearly 9.1 million animal bites and 5,726 human rabies deaths due to dog bites are estimated to occur every year in India. 80 per cent of the dog bite v ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.